Skip to content
CIS Pharma logo — Innovation made in Switzerland

CIS Pharma

Innovation made in Switzerland

Founded 1952 Switzerland Switzerland 5 employees Biotechnology, Fashion +3

General Information

Company Name CIS Pharma
Founded Year 1952
Location Switzerland Switzerland
Employees 5
Industries Biotechnology, Fashion, Life Sciences +2
Social

BounceWatch is an independent company data service, not affiliated with CIS Pharma. To contact CIS Pharma, visit cis-pharma.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does CIS Pharma compare?

A PDF of CIS Pharma and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting CIS Pharma soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About CIS Pharma

CIS Pharma is a biopharmaceutical company based in the Basel Area, Switzerland. Specializing in the development of next-gen immuno-conjugates, ADCs, and radioligand treatments, the company targets cancer patients with poor prognosis and a high spread of metastases. With assets including two targeting moieties against CD 171 and CD 276, as well as a polymer carrier technology, CIS Pharma aims to overcome current limitations in immuno-conjugates. Their technology stands out for its high-yield labeling of proteins, increased DAR, and precision in creating combination therapies.

Founded in 1952, CIS Pharma operates in the Biotechnology and Pharmaceutical industries, showcasing a long-standing commitment to innovation. While the latest investment details are not available, the company's focus on pioneering cancer treatments in Switzerland solidifies its position as an attractive prospect for potential venture capital involvement.

Business keywords: Biopharmaceutical, Cancer treatment, Immunotherapy, Next-generation drugs, Targeted therapies, Radioligand therapy, Precision medicine, ADCs, Bioconjugates, Radionuclide therapy, Polymer carriers, Innovative drug delivery, Precision combination therapies

No funding data available for CIS Pharma yet.

CIS Pharma Alternatives & Competitors

View All Alternatives
CIS Pharma vs
Endocyte
Endocyte United States

Endocyte is a biopharmaceutical company and leader in developing targeted therapies for the personal...

Debt Financing
16 employees
Biotechnology, Health Care
CIS Pharma vs
Apollomics
Apollomics United States

We are a biopharmaceutical company committed to the discovery and development of mono- and combinati...

Post-IPO Equity
26 employees
Biotechnology, Health Care
CIS Pharma vs

Dedicated to the discovery, development, and commercialization of novel targeted therapies to treat...

Post-IPO Equity
1 employees
Biotechnology, Health Care

FAQ About CIS Pharma

Innovation made in Switzerland
CIS Pharma was founded in 1952.
CIS Pharma is headquartered in Switzerland.
CIS Pharma operates in Biotechnology, Fashion, Life Sciences, Medical Devices and Pharmaceutical. Its work centres on Biopharmaceutical, Cancer treatment, Immunotherapy and Next-generation drugs.
CIS Pharma has approximately 5 employees.
Top alternatives and competitors to CIS Pharma include Endocyte, Apollomics, Anchiano Therapeutics, NEOGAP Therapeutics AB, Lisata Therapeutics, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CIS Pharma and Endocyte are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for CIS Pharma, https://bouncewatch.com/company/cis-pharma, updated 27 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout